Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Duloxetine for Negative Symptoms in Schizophrenia with NRG1 Risk Genotype
NCT01078870Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, duloxetine in schizophrenia, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
escitalopramduloxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01078870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078870.